Human Siglec-3/CD33 (Research Grade Gemtuzumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB9635SP	R&D Systems MAB9635SP	25 μg
MAB9635100	R&D Systems MAB9635100	100 μg

Description

Siglec-3/CD33 Monoclonal specifically detects Siglec-3/CD33 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: Siglec-3/CD33
• Dilution: Flow Cytometry 0.25μg/10⁶ cells, CyTOF-ready
• Classification: Monoclonal
• Form: Supernatant
• Target Species: Human
• Gene Alias: CD33, CD33 antigen, CD33 antigen (gp67), CD33 molecule, FLJ00391, gp67, myeloid cell surface antigen CD33, p67, sialic acid binding Ig-like lectin 3, Sialic acid-binding Ig-like lectin 3, Siglec3, SIGLEC-3, SIGLEC3gp67
• Immunogen: Human Siglec-3/CD33
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5mg/mL in sterile PBS.
• Test Specificity: Detects human Siglec-3/CD33 based on Gemtuzumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Gemtuzumab. This product is for research use only.

• Clone: Hu9a
• Applications: CyTOF, Flow Cytometry
• Conjugate: Unconjugated
• Host Species: Human
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 945
• Isotype: IgG1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.